Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
TRANSCEND-T2D-1: Retatrutide Phase 3 Diabetes Results (March 2026) First Phase 3 retatrutide trial in type 2 diabetes 16.8% weight loss and -2.0% A1C at 12 mg over 40 weeks
Since retatrutide is a weekly injection, the daily tesamorelin schedule would continue independently
Will retatrutide be available globally at launch
Right now, researchers are looking at how well retatrutide works, how safe it is over time, and what the best ways to use it might be
This careful evaluation of plan details can make a substantial difference in your access to needed medications
Conversely, semaglutide is more effective at supporting weight loss than liraglutide but is better tolerated, according to a recent randomised controlled trial
US$ 24.90
%20copy.jpg)
US$ 22.70
US$ 24.56
